Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G expression in hematologic malignancies
Wei‐Hua Yan
Expert Review of Hematology (2010) Vol. 3, Iss. 1, pp. 67-80
Closed Access | Times Cited: 22

Showing 22 citing articles:

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
Thomas Menter, Alexandar Tzankov
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 65
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58
HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer
Aifen Lin, Xia Zhang, Yanyun Ruan, et al.
Lung Cancer (2011) Vol. 74, Iss. 3, pp. 504-509
Closed Access | Times Cited: 51
HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin, Xia Zhang, Huihui Xu, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 1, pp. 150-157
Closed Access | Times Cited: 41
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
Angela Dardano, Roberta Rizzo, Antonio Polini, et al.
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 11, pp. 4080-4086
Open Access | Times Cited: 39
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 576-589
Closed Access | Times Cited: 35
NK cytolysis is dependent on the proportion of HLA-G expression
Baoguo Chen, Dan‐Ping Xu, Aifen Lin, et al.
Human Immunology (2012) Vol. 74, Iss. 3, pp. 286-289
Closed Access | Times Cited: 38
Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma
Yongfu Xu, Hai-Xiong Han, Fabiao Zhang, et al.
Oncology Letters (2014) Vol. 9, Iss. 1, pp. 300-304
Open Access | Times Cited: 26
Significance of tumour cell HLA‐G5/‐G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients
Wei‐Hua Yan, Di Liu, Haiyan Lu, et al.
Journal of Cellular and Molecular Medicine (2015) Vol. 19, Iss. 4, pp. 778-785
Open Access | Times Cited: 23
HLA-G regulators in cancer medicine: an outline of key requirements
Inès Zidi, Nidhal Ben Amor
Tumor Biology (2011) Vol. 32, Iss. 6, pp. 1071-1086
Closed Access | Times Cited: 18
Immunomodulation of classical and non-classical HLA molecules by ionizing radiation
Cristina E. Gallegos, Severino Michelin, Diana Dubner, et al.
Cellular Immunology (2016) Vol. 303, pp. 16-23
Closed Access | Times Cited: 15
Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies
Xiaoshuai Zhou, Qiufeng Zhang, Dongying Wang, et al.
Gut and Liver (2024) Vol. 18, Iss. 5, pp. 845-856
Open Access | Times Cited: 1
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia
Giovanni Caocci, Marianna Greco, Marcella Arras, et al.
Leukemia Research (2017) Vol. 61, pp. 1-5
Open Access | Times Cited: 14
HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
Dorota Jesionek‐Kupnicka, Marcin Bojo, Monika Prochorec–Sobieszek, et al.
Archivum Immunologiae et Therapiae Experimentalis (2015) Vol. 64, Iss. 3, pp. 225-240
Closed Access | Times Cited: 12
Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers
Huihui Xu, Jun Gan, Dan‐Ping Xu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
HLA-G5 in the blood of leukemia patients and healthy individuals
K Poláková, T Zelezníková, Gustáv Russ
Leukemia Research (2012) Vol. 37, Iss. 2, pp. 139-145
Closed Access | Times Cited: 7
Serum Human Leukocyte Antigen-G and Soluble Interleukin 2 Receptor Levels in Acute Lymphoblastic Leukemic Pediatric Patients
Tarek K. Motawi, Nadia I. Zakhary, Tarek Salman, et al.
Asian Pacific Journal of Cancer Prevention (2012) Vol. 13, Iss. 11, pp. 5399-5403
Open Access | Times Cited: 6
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
Alan W. Hodges, Rachel Dubuque, Shu‐Hsia Chen, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Human Leukocyte Antigen (HLA) Molecules and Ionizing
Severino Michelin, Diana Dubner
(2014)
Closed Access
Structure and Function of HLA-G
Saeideh Sadat Shobeiri, Versa Omrani‐Nava, Saeid Abediankenari
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences (2015) Vol. 24, Iss. 122, pp. 407-423
Closed Access
Classical HLA class I antigen downregulation and abnormal HLA-G expression in ovarian cancer
Min Jong Song, Suk Ki Jang, Hyon Yoon, et al.
European Journal of Gynaecological Oncology (2021) Vol. 42, Iss. 1, pp. 129-129
Open Access
Page 1

Scroll to top